REVEAL GENOMICS®️ ANNOUNCES RESEARCH COLLABORATION IN HER2+ BREAST CANCER ...Middle East

The agreement with Dana-Farber Cancer Institute consists of using HER2DX®️ to analyze tumor samples from more than 500 patients with early-stage HER2+ breast cancer across three clinical trials (APT, ATEMPT, and DAPHNE). The three completed studies were essential in establishing new...

Hence then, the article about reveal genomics announces research collaboration in her2 breast cancer was published today ( Thursday 28/04/2022 - 03:15 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( REVEAL GENOMICS®️ ANNOUNCES RESEARCH COLLABORATION IN HER2+ BREAST CANCER )

Also on site :

• Aura AI Assistant for Unreal Engine Launches: VR Studio Ships Game in Half the Time with New Agent Capabilities
• Man accused of placing pipe bombs near GOP and Democratic headquarters in Washington to remain in jail pending trial
• FDA Clears BrainSpace Intellidrop, an automated neuro device that addresses ICU nursing shortages and builds training data for Physical AI